AMN Healthcare Reports Second Quarter 2024 Financial Results
Intellectia.AI1970-01-01
AMN Healthcare Reports Second Quarter 2024 Financial Results
AMN Healthcare Services, Inc. (NYSE: AMN), the leader in total talent solutions for healthcare organizations across the United States, announced its financial results for the second quarter of 2024.
Key Financial Metrics
| Metric | Q2 2024 Actuals | Q2 2024 Consensus | Q2 2023 Actuals | Q1 2024 Actuals | Year-over-Year Change | Quarter-over-Quarter Change |
|---|---|---|---|---|---|---|
| Total Revenue | $741 million | $740.43 million | $988 million | $823 million | -25% | -10% |
| GAAP EPS | $0.42 | $1.55 | -72% | |||
| Adjusted EPS | $0.98 | $0.76 | $2.38 | -59% |
The reported revenue aligns closely with expectations while earnings per share exceeded consensus estimates. The decline in revenue and earnings compared to the previous year highlights challenges primarily from decreased demand in the Nurse and Allied Solutions segment. Effective expense management and beneficial discrete items contributed to better-than-expected earnings.
Revenue Performance by Segment
| Segment | Q2 2024 Revenue | Year-over-Year Change | Quarter-over-Quarter Change |
|---|---|---|---|
| Nurse and Allied Solutions | $442 million | -36% | -15% |
| Physician and Leadership Solutions | $186 million | +6% | -1% |
| Technology and Workforce Solutions | $112 million | -11% | < -1% |
| - Language Services | $75 million | +18% | +5% |
| - Vendor Management Systems | $28 million | -41% | -5% |
The performance of the Nurse and Allied Solutions segment showed significant declines, primarily driven by reductions in travel nurse staffing. On the other hand, the Physician and Leadership Solutions segment demonstrated moderate growth year-over-year, with locum tenens seeing a 17% increase. The Technology and Workforce Solutions segment witnessed growth in language services, counterbalanced by a decline in vendor management systems revenue.
Key Operational Data
| Operational Metric | Q2 2024 Value |
|---|---|
| Cash flow from operations | $100 million |
| Debt reduction | $80 million |
| Net leverage ratio | 2.6:1 |
AMN Healthcare reported robust operational cash flow, enabling substantial debt reduction during the quarter.
Executive Comments
Cary Grace, President and Chief Executive Officer, highlighted AMN's progress despite market challenges, particularly in the travel nurse sector. She emphasized the diversification of AMN's solutions and the company's effective expense management as critical factors in maintaining profitability.
Forward Guidance
Revenue for the third quarter of 2024 is expected to be 20-23% lower year-over-year and 8-10% lower sequentially. Specific segment forecasts include a 32-34% year-over-year decline in the Nurse and Allied Solutions segment, 12-14% growth in the Physician and Leadership Solutions segment, and a 10-12% year-over-year decrease in the Technology and Workforce Solutions segment.
Stock Price Movement
AMN's stock price experienced a 3.63% increase following the earnings release.
In summary, AMN Healthcare managed to exceed earnings expectations despite facing significant revenue challenges, with future strategies focusing on diversification and expense control to navigate the fluctuating market dynamics.
Genasys Inc Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
Toll Brothers Reports Fourth Quarter and Full Year 2024 Financial Results
OilDri Corporation of America Reports Record First Quarter Fiscal 2025 Results
Share